Projects
Support in getting insights in SARS-CoV-2 transmission dynamics in Brussels region and support the detection of clusters Institute of Tropical Medicine
1) Through systematic analyses of available data, support the identification of active clusters and prioritisation in contact tracing follow-up by the hygiene team.
2) Report on the call centre data and contact tracing performance indicators, to help identify necessary improvements in data collection for epidemiological insights, description and identification of clusters.
3) Conduct in-depth analyses of ...
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during one year of the COVID-19 epidemic. University of Antwerp
Prohylaxis of at risks persons with an ultrapotent SARS-CoV-2 neutralizing antibody. KU Leuven
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which causes COVID-19, has now spread all over the globe, infected
millions, and already killed more than 150.000 people. Elderly people
are most likely to develop severe disease and to die from COVID-19.
The aim of this project is to have a manufacturable, cost-effective,
ultrapotent SARS-CoV-2-neutralizing antibody ready for ...
Investigation of the SARS-CoV-2. KU Leuven
Het doel van het project is om een innovatief in-vitro model te ontwikkelen om de communicatie tussen endotheelcellen en epitheelcellen van de luchtwegen te karakteriseren tijdens SARS-CoV-2 virale infectie.
Prevalence and incidence of antibodies against SARS-CoV-2 in children measured for one year in Belgium: A sero-epidemiological prospective cohort study KU Leuven
Collaboration between Sciensano and KU Leuven about the prevalence and incidence of antibodies against SARS-CoV-2 in a sample of school-aged children and school staff (primary and secondary school) and primary school children only in Belgium at different time points.
Assessment and follow-up of SARS-CoV-2 infection in pregnant women and neonates. University of Antwerp
Entry inhibitors for human respiratory virus SARS-CoV-2. KU Leuven
Despite the clear success of the administered COVID-19 vaccines, we still cannot control the spread of SARS-CoV-2, as evidenced by the current circulation of the highly contagious Omicron variant. This highlights the need to continue with the development of effective broad-spectrum antivirals that can be used to rapidly diminish viral spread when an epidemic with a (re-)emerging virus occurs. Candidate SARS-CoV-2 inhibitors should show broad ...
Inter- and intra-community dynamics of SARS-CoV-2 spread by whole-genome sequencing and phylodynamic analysis KU Leuven
Since the introduction of SARS-CoV-2, the virus has been spreading
very rapidly and has caused severe respiratory pathology around the world. A pandemie ensued within
a short time. The virus originated from a zoonotic event, where likely a bat or even a pangolin was
carrying the virus and infected a human by animal-to-human transmission. This means that the virus
is still seeking an optimal fit with its new host, the ...